Enfuvirtide Acetate (T-20)
Detailed Description
Enfuvirtide Acetate (T-20)
Sequence CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu
-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-
Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys
-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2
Cas No. 159519-65-0
Molecular Formula C204H301N51O64
Molecular Weight 4492
Purity (HPLC) 98.0%min.
Appearance White to off-white amorphous solid
Single Impurity (HPLC) 0.5%max
Amino Acid Composition ≤10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content (Karl Fischer) ≤8.0%
TrifluoroAcetate Content(HPIC) ≤12.0%
MS (ESI) Consistent
Mass Balance 95.0~105.0%
Cosmetic peptides:
1, Matrixyl Acetate (Palmitoyl Pentapeptide)
2, Argireline Acetate (Acetyl Hexapeptide-3)
3, Lipopeptide Acetate
4,SNAP-8 (Acetyl Glutamyl Heptapeptide-3)
5,Dipeptide-2
6,Palmitoyl Tripeptide-5(Palmitoyl Oligopeptide)
7,Kollaren/tripeptide-1
8.Matrixyl 3000
- Enfuvirtide Acetate (T-20)